Abstract
During last five decades, liposomes are well developed as delivery carriers for various molecules and can form unilamellar or multilamellar lipid vesicles. To design liposomal formulations for tumor therapy, administration by intravenous injection is a main option. Considering that sometimes anticancer drug needs higher dose (e.g., ~50 mg/m2 for doxorubicin), the stable drug-loading method must be explored for the practical use of drug liposomes during storage and in circulation. Conventional preparation approaches are impossible to reach higher drug encapsulation because of the nature of the poor drug solubility. The issue of low drug-loading rate would make therapeutic potential of drugs in low levels and cannot reach clinic use. The development of remote loading can also overcome the instability when loading with high internal concentrations of drugs. Transmembrane pH gradients in liposomal carrier can be helpful to promote the encapsulation of various commonly used drugs and fluorescent probes. In fact, pH-gradient method is the first use of remote loading approaches. The transmembrane ion gradients can be constructed by adopting salts composes either weak bases or weak acids. The degree of ionization of these drugs is pH dependent. Their ionized forms have a very low permeability coefficient, while their unionized species have high permeability and can diffuse relatively fast across liposome lipid bilayer to reach the intraliposomes. pH-gradient method provides a basic insight to develop other remote loading methods.
Similar content being viewed by others
References
Bangham AD, Standish MM, Watkins JC (1965) Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13(1):238–252
Barenholz Y (2012) Doxil® – the first FDA-approved nano-drug: lessons learned. J Control Release 160(2):117–134
Brown JM (2002) Tumor microenvironment and the response to anticancer therapy. Cancer Biol Ther 1(5):453–458
Brown JM, Giaccia AJ (1998) The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 58(7):1408–1416
Burade V, Bhowmick S, Maiti K, Zalawadia R, Ruan H, Thennati R (2017) Lipodox® (generic doxorubicin hydrochloride liposome injection): in vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse models. BMC Cancer 17(1):405
Cagel M, Grotz E, Bernabeu E, Moretton MA, Chiappetta DA (2017a) Doxorubicin: nanotechnological overviews from bench to bedside. Drug Discov Today 22(2):270–281
Cagel M, Grotz E, Bernabeu E, Moretton MA, Chiappetta DA (2017b) Doxorubicin: nanotechnological overviews from bench to bedside. Drug Discov Today 22(2):270–281
Cern A, Golbraikh A, Sedykh A, Tropsha A, Barenholz Y, Goldblum A (2012) Quantitative structure-property relationship modeling of remote liposome loading of drugs. J Control Release 160(2):147–157
Deamer DW, Prince RC, Crofts AR (1972) The response of fluorescent amines to pH gradients across liposome membranes. Biochim Biophys Acta 274(2):323–335
Dos Santos N, Cox KA, McKenzie CA, van Baarda F, Gallagher RC, Karlsson G, Edwards K, Mayer LD, Allen C, Bally MB (2004) pH gradient loading of anthracyclines into cholesterol-free liposomes: enhancing drug loading rates through use of ethanol. Biochim Biophys Acta 1661(1):47–60
Elizondo E, Moreno E, Cabrera I, Córdoba A, Sala S, Veciana J, Ventosa N (2011) Liposomes and other vesicular systems: structural characteristics, methods of preparation, and use in nanomedicine. Prog Mol Biol Transl Sci 104:1–52
Gabizon A, Tzemach D, Mak L, Bronstein M, Horowitz AT (2002) Dose dependency of pharmacokinetics and therapeutic efficacy of pegylated liposomal doxorubicin (DOXIL) in murine models. J Drug Target 10(7):539–548
Giddam AK, Zaman M, Skwarczynski M, Toth I (2012) Liposome-based delivery system for vaccine candidates: constructing an effective formulation. Nanomedicine (Lond) 7(12):1877–1893
Greish K (2007) Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J Drug Target 15(7–8):457–464
Hadjidemetriou M, Al-Ahmady Z, Kostarelos K (2016) Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles. Nanoscale 8(13):6948–6957
Haran G, Cohen R, Bar LK, Barenholz Y (1993) Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim Biophys Acta 1151(2):201–215
Ichihara H, Hino M, Umebayashi M, Matsumoto Y, Ueoka R (2012) Intravenous injection of hybrid liposomes suppresses the liver metastases in xenograft mouse models of colorectal cancer in vivo. Eur J Med Chem 57:143–148
Mayer LD, Bally MB, Cullis PR (1986) Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochim Biophys Acta 857(1):123–126
Mineart KP, Kelley EG, Nagao M, Prabhu VM (2017) Processing-structure relationships of poly(ethylene glycol)-modified liposomes. Soft Matter 13(31):5228–5232
Mozafari MR (2005) Liposomes: an overview of manufacturing techniques. Cell Mol Biol Lett 10(4):711–719
Pantos A, Tsiourvas D, Paleos CM, Nounesis G (2005) Enhanced drug transport from unilamellar to multilamellar liposomes induced by molecular recognition of their lipid membranes. Langmuir 21(15):6696–6702
Perrie Y, Kastner E, Khadke S, Roces CB, Stone P (2017) Manufacturing methods for liposome adjuvants. Methods Mol Biol 1494:127–144
Qi XR, Yan WW, Shi J (2005) Hepatocytes targeting of cationic liposomes modified with soybean sterylglucoside and polyethylene glycol. World J Gastroenterol 11(32):4947–4952
Redelmeier TE, Mayer LD, Wong KF, Bally MB, Cullis PR (1989) Proton flux in large unilamellar vesicles in response to membrane potentials and pH gradients. Biophys J 56(2):385–393
Russell LM, Dawidczyk CM, Searson PC (2017) Quantitative evaluation of the enhanced permeability and retention (EPR) effect. Methods Mol Biol 1530:247–254
Satish PR, Surolia A (2002) Preparation and characterization of glycolipid-bearing multilamellar and unilamellar liposomes. Methods Mol Biol 199:193–202
Schwendener R, Schott H (2005) Lipophilic arabinofuranosyl cytosine derivatives in liposomes. Methods Enzymol 391:58–70
Sehgal S, Rogers JA (1995) Polymer-coated liposomes: improved liposome stability and release of cytosine arabinoside (Ara-C). J Microencapsul 12(1):37–47
Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S (2015) Advances and challenges of liposome assisted drug delivery. Front Pharmacol 6:286
Shapiro CL, Ervin T, Welles L, Azarnia N, Keating J, Hayes DF (1999) Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer. TLC D-99 study group. J Clin Oncol 17(5):1435–1441
Shi J, Yan WW, Qi XR, Maitani Y, Nagai T (2005) Characteristics and biodistribution of soybean sterylglucoside and polyethylene glycol-modified cationic liposomes and their complexes with antisense oligodeoxynucleotide. Drug Deliv 12(6):349–356
Shimizu K, Osada M, Takemoto K, Yamamoto Y, Asai T, Oku N (2010) Temperature-dependent transfer of amphotericin B from liposomal membrane of AmBisome to fungal cell membrane. J Control Release 141(2):208–215
Sideratou Z, Sterioti N, Tsiourvas D, Paleos CM (2009) Structural features of interacting complementary liposomes promoting formation of multicompartment structures. Chem Phys Chem 10(17):3083–3089
Sur S, Fries AC, Kinzler KW, Zhou S, Vogelstein B (2014) Remote loading of preencapsulated drugs into stealth liposomes. Proc Natl Acad Sci U S A 111(6):2283–2288
Xing H, Hwang K, Lu Y (2016) Recent developments of liposomes as nanocarriers for theranostic applications. Theranostics 6(9):1336–1352
Yang Q, Ma Y, Zhao Y, She Z, Wang L, Li J, Wang C, Deng Y (2013) Accelerated drug release and clearance of PEGylated epirubicin liposomes following repeated injections: a new challenge for sequential low-dose chemotherapy. Int J Nanomedicine 8:1257–1268
Zhao W, Zhuang S, Qi XR (2011) Comparative study of the in vitro and in vivo characteristics of cationic and neutral liposomes. Int J Nanomedicine 6:3087–3098
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Shi, NQ., Qi, XR., Xiang, B. (2021). Preparation and Characterization of Drug Liposomes by pH-Gradient Method. In: Lu, WL., Qi, XR. (eds) Liposome-Based Drug Delivery Systems. Biomaterial Engineering. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-49320-5_18
Download citation
DOI: https://doi.org/10.1007/978-3-662-49320-5_18
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-49318-2
Online ISBN: 978-3-662-49320-5
eBook Packages: Chemistry and Materials ScienceReference Module Physical and Materials ScienceReference Module Chemistry, Materials and Physics